| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | $5,095,428 | -22,830 | -0.4% | $223.19 | 5,616,585 | 23 Dec 2021 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | $8,856,955 | -39,171 | -0.7% | $226.11 | 5,577,414 | 27 Dec 2021 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $219.94 to $224.68. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $223.28 to $227.87. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |